Linamar (OTCMKTS:LIMAF) Shares Pass Below 50 Day Moving Average of $31.07

Share on StockTwits

Linamar Co. (OTCMKTS:LIMAF) shares passed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $31.07 and traded as low as $30.88. Linamar shares last traded at $32.30, with a volume of 6,500 shares trading hands.

The stock’s fifty day simple moving average is $31.12 and its two-hundred day simple moving average is $33.58.

Linamar Company Profile (OTCMKTS:LIMAF)

Linamar Corporation manufactures and sells precision metallic components, modules, and systems in Canada, the Rest of North America, the Asia Pacific, Mexico, and Europe. It operates through two segments, Industrial and Transportation. The company offers hybrid power units, power transfer units, rear drive units/modules, and engineered gears; and shaft and shell assemblies, differential assemblies, transmission gears, clutch modules, center housings, transmission/driveline shafts, transfer case pump housings, and other transmission components.

Featured Story: Earnings Reports

Receive News & Ratings for Linamar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Linamar and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

SunOpta, Inc.  Senior Officer Robert Duchscher Purchases 5,100 Shares
SunOpta, Inc. Senior Officer Robert Duchscher Purchases 5,100 Shares
Ironwood Pharmaceuticals, Inc.  CAO Kelly Macdonald Sells 987 Shares
Ironwood Pharmaceuticals, Inc. CAO Kelly Macdonald Sells 987 Shares
Galway Metals Inc  Director Robert Hinchcliffe Acquires 45,000 Shares
Galway Metals Inc Director Robert Hinchcliffe Acquires 45,000 Shares
Insider Buying: TORTOISE ESSENT/COM SH BEN INT  Insider Buys 1,300 Shares of Stock
Insider Buying: TORTOISE ESSENT/COM SH BEN INT Insider Buys 1,300 Shares of Stock
FY2019 EPS Estimates for Encore Capital Group, Inc.  Boosted by Oppenheimer
FY2019 EPS Estimates for Encore Capital Group, Inc. Boosted by Oppenheimer
Scpharmaceuticals Inc  Short Interest Update
Scpharmaceuticals Inc Short Interest Update


 
© 2006-2019 Zolmax.